The Journal of Community and Supportive Oncology - 16(1)

Abemaciclib becomes first CDK inhibitor to clinch single-agent approval for breast cancer

Checkpoint inhibitors forge new treatment paradigm for metastatic bladder cancer

Analgesic management in radiation oncology for painful bone metastases

Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States

Concurrent ipilimumab and CMV colitis refractory to oral steroids

Recurrent head and neck cancer presenting as a large retroperitoneal mass

Massive liver metastasis from colon adenocarcinoma causing cardiac tamponade